Information Provided By: 
Fly News Breaks for June 22, 2016
EXAS
Jun 22, 2016 | 09:46 EDT
After conducting checks, Craig-Hallum believes that large insurers will probably cover Exact Sciences' Cologuard test. The firm says that the final colorectal cancer screening recommendation issued by the USPSTF last week.will spur payors to cover the test. The firm thinks that a decision by a national insurer to cover Cologuard will prove to be "a significant catalyst" for Exact Sciences' stock. Craig-Hallum reiterates an $18 price target and Buy rating on the shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
